Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) Tops Q3 EPS by 5c, Revenues Beat; Revises FY19 EPS/Revenue Guidance

October 22, 2019 6:49 AM
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.76, $0.05 better than the analyst estimate of $1.71. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles